H7 BioCapital

📢 Applications are now open for the H7 Investment Fellowship 2024 H2 Cohort! This fellowship seeks candidates with a Ph.D. or M.D. and experience in the pharmaceutical or biotech industry. While experience in venture capital, consulting, or business development is preferred, it is not required. 📅 Application deadline: November 8, 2024 🚀 Program start date: December 1, 2024 🔗 Application link: https://shorturl.at/ZUhhj #investment #phd #biotech #lifescience #fellowship #pharmaceutical #VC

🚀 Get ready for the 7th event in the #H7Healthcare Workshop Series 2024! 💥Join us for "Navigating Growth in the Healthcare Sector: Strategies for Early-Stage Innovators" with Devin Deich, MBA / MHA , IDC.D., ACHE, founder of Diverge Health. 💥 This workshop will explore actionable insights on key areas critical to success. We’ll dive into scaling operations efficiently through organizational alignment, leveraging regulatory complexities to ensure market advantage and fit, and fostering the right organizational culture for rapid growth. Additionally, we will cover practical strategies for revenue generation and selecting funding partners, equipping your company with the tools to thrive in a highly competitive environment. 📍Topics: - Scaling operations efficiently. - Leveraging regulatory complexities. - Fostering leadership for rapid growth. - Generating consistent revenue in healthcare. Date: Tuesday, October 29, 2024   Time: 10:30 am PST     For more details, contact info@h7biocapital.com or visit www.h7biocapital.com. #HealthcareGrowth #StartupStrategies #RegulatoryAdvantage #RevenueGeneration #H7BioCapital

🚀 Get ready for the 6th event in the #H7Healthcare Workshop Series 2024! 💥Join us for "Venture Financing Structures: SAFEs, Convertible Notes, and Preferred Stock Financings" with Sale Kwon, Partner of Cooley LLP. 💥 This workshop is intended for early stage companies that are seeking to raise capital from venture capital investors in the U.S. The workshop will provide a high level overview of common venture financing structures, namely, SAFEs, convertible notes and preferred stock financings, and their core terms. The goal is help aspiring venture-backed companies understand these financing structures and core terms that come with them including their goals and rationale so that they can negotiate and choose a legal structure and terms that are appropriate for their situation. 📍Topics: - Key venture financing structures. - Major terms in SAFE and convertible note financings. - Negotiating preferred stock financings for growth. Date: Wednesday, October 23, 2024   Time: 10:30 am PST     For more details, contact info@h7biocapital.com or visit www.h7biocapital.com. #VentureFinancing #SAFEs #ConvertibleNotes #PreferredStock #StartupFunding #H7BioCapital

🔥 Join us for the next H7 Angel Club deal meeting on Friday, October 18th at 3pm PST via Zoom!  🚩 Featured Company: a clinical-stage biotech developing First-in-Class drug candidates for chronic liver disease. Founded by serial scientific entrepreneurs with multiple 💥 successful exits in the liver disease field💥, the company’s lead compound, currently in Phase I clinical trial, is the only MASH candidate targeting all major mechanisms simultaneously—hepatic steatosis, inflammation, and fibrosis—with strong efficacy data supporting its potential. 📣 H7 investment team has thoroughly reviewed the project and prepared a 📝[One-Pager Investment Teaser] along with a comprehensive ✍️ [Investment Report exceeding 30 pages]. Upon signing and NDA, we are delighted to provide access to the full report.  ----------- The meeting is exclusively for investor members of H7 Angel Club, which is entirely free for qualified investors. Apply for membership to attend. Upon approval, you’ll receive further details. 🎯Investor Membership Application: https://shorturl.at/losSW 🎯Founders Submitting Their Deck: https://shorturl.at/d3UBO #angel #investmentopportunity #vc #healthcare #lifesciences #medtech #medicaldevices #biotech #biopharma #investors #familyoffice #syndicate #fundraising #clinical

🚀 Join us for the 5th event in the #H7Healthcare Workshop Series 2024! 💥Join us for "Building for Growth Requires Getting GTM Right" with Donald B. Hawthorne, President of GTM® Hawthorne, Inc.. 💥In this workshop, we will tackle the disconnect between a reality where roughly 70% of offerings flop or fail outright while nearly 100% of executives believe their offerings fall in the remaining 30%. Donald will share how that disconnect is resolved by Getting GTM Right. He will also describe both the mindset necessary for GTM success and offer tools he uses to guide companies in developing GTM strategies that make it possible for them to win in the marketplace. 📍Topics: - Creating customer value through GTM strategies. - Aligning GTM efforts with customer needs. - Real-world examples from over 30 years in life science startups. Date: Tuesday, October 15, 2024   Time: 10:30 am PST     For more details, contact info@h7biocapital.com or visit www.h7biocapital.com. #GrowthStrategies #GoToMarket #LifeSciences #StartupLeadership #H7BioCapital

🌟 Announcing the 4th 2024 #H7Healthcare Workshop Series event on October 8th! 💥Join us for "Navigating the Negotiation Process: Key Strategies for Successful Term Sheets in Venture Financing" with Ruming Liu, Partner at MagStone Law, LLP. 💥In this workshop, we will cover an insightful seminar on Venture Financing. We’ll delve into the critical components of term sheets, including negotiation strategies, investor rights, and founder protections. Led by experienced professionals, this session will guide you through the startup formation and financing process, highlighting essential strategies for financing process. Gain valuable insights into corporate governance.  Perfect for founders and investors looking to strengthen their understanding of venture financing. 📍Topics: - Preparing for the financing: founder shares, vesting, IP assignment, stock incentive plan - Venture Financing Guidance: Strategic capital, mentorship, investor connections. - Term Sheet Essentials: Pre-money valuation, preferential rights, liquidation preference. - Corporate Control: Super-voting shares, board composition, executives - The impact of regulatory milestones on asset valuation. Date: Tuesday, October 8, 2024   Time: 10:30 am PST     For more details, contact info@h7biocapital.com or visit www.h7biocapital.com. #VentureFinancing #TermSheetStrategies #BusinessNegotiations #StartupFunding #H7BioCapital #heatlhcare

Our founding Partner 🌟 Ella Li, Ph.D. 👑will serve as a judge for the Unicorn Battle U.S. on October 8th! Join us at 10 am PDT for live pitches from leading startups in Biotech, HealthTech, AI, FinTech, Cybersecurity, and more!  🗓 Date: October 8th, 2024 🕙 Time: 10:00 AM - 12:00 PM GMT-7 📍 Location: Zoom (Online) 💰 Cost: FREE

🌟 Announcing the 3rd 2024 #H7Healthcare Workshop Series event on October 1st! 💥Join Ernesto Chanona, Vice President at CSSi LifeSciences, for "MedTech Innovation: Regulatory Strategy for Commercial Success." 💥In this workshop, we will cover the use of a regulatory thesis, the role of a regulatory affairs professional, and the US FDA regulatory pathways for medical devices. We will also explore strategies for navigating these processes effectively. Additionally, we will address common myths about the US FDA, and discuss how regulatory milestones can impact the valuation of an asset and influence the probability of out-licensing. 📍Topics: - The role of regulatory affairs in device commercialization. - Navigating FDA approval processes. - Debunking common FDA myths. - The impact of regulatory milestones on asset valuation. Date: Tuesday, October 1, 2024   Time: 10:30 am PST     For more details, contact info@h7biocapital.com or visit www.h7biocapital.com. #Medtech #MedicalDeviceInnovation #FDAApproval #RegulatoryAffairs #HealthcareInnovation #H7BioCapital 

Don't miss the Grand Finale of Startup World Cup 2024 on October 4th in San Francisco! 🎯 Register to attend the Grand Final: https://shorturl.at/0pmWv 🌟 Use discount code: SWC_GF_ELLA_20 to secure your spot.

👏 Introducing H7 Accelerator 2024 Cohort, powered by H7 BioCapital! 👏 🔥 This year, we received hundreds of applications from around the globe, and we are excited to announce the 9 exceptional companies joining the #H7 Accelerator 2024 cohort 🎉. Our cohort showcases a diverse lineup: 2 in #biotech, 3 in digital medicine, and 4 in medical devices, representing various stages of growth with 1 in Series A, 5 in Seed, and 3 in Pre-Seed. Geographically, 8 companies are based in the U.S., with 1 hailing from Germany. Dive into the profiles of our exceptional 2024 cohort through the links below. 🎉Congratulations to all the founders joining this journey: John Ashley, Trevor Vieweg, David Mead, Shian-Jiun Shih, Lisa Kinsella, Kevin Shrock, Jule Ehrlich, Dominik Burziwoda, and Joshua Park. - Auctus Surgical, Inc.: offers a revolutionary flexible tether for scoliosis surgery in children, allowing continuous spinal correction with natural movement preservation, adjustable through a magnetic controller as the child grows. - Limmi: healthcare AI company that offers a comprehensive, HIPAA and FDA-compliant platform for data integration, model training, and deployment, accelerating innovation and improving patient outcomes by uncovering hidden patterns in healthcare data. - Terra Bioforge: Terra Bioforge revolutionizes microbial strain engineering with advanced genome tools, accelerating R&D, enhancing fermentation efficiency, and reducing production costs for Pharma and Agtech sectors. - Cellentia: Cellentia offers a cutting-edge platform using circulating tumor cell-derived organoids for AI-assisted drug screening and monitoring of metastatic solid tumors, enhancing drug development and personalized oncology research. - Perfood: develops digital therapeutics that use continuous glucose monitoring and AI to create personalized nutrition plans, addressing metabolic, neuro-inflammatory, and immunological conditions. - LUWI: offers a hormone-free, latex-free contraceptive liner designed for women, providing a more comfortable and sensation-enhancing alternative to traditional condoms. - Blink by Globe Biomedical: smart eyewear equipped with advanced sensors and AI for real-time, non-invasive monitoring of eye health and early detection of vision issues. - WhichDocs: digital database that connects patients with healthcare providers using highly accurate listings, focusing on the Workers' Compensation industry and partnering with organizations like the Florida Medical Association to enhance provider accuracy and efficiency. - Regenova Pharma: uses advanced deep learning models with over 90% accuracy to revolutionize large molecule drug discovery, focusing on infectious diseases and oncology, and seeks strategic partnerships to accelerate the development of novel therapeutics. 🎯 More about H7 BioCapital: https://lnkd.in/gxH3cGjC #biotech #lifescience #medtech #digitalmedicine #medicaldevice #accelerator #venture